World-Class Community Oncology/Hematology
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. With more than 250 physicians, 220 advanced practice providers and nearly 100 offices located throughout the state, we are committed to providing world-class cancer care in community-based settings close to home.
Unsurpassed Clinical Trial Research
As a strategic partner of Sarah Cannon Research Institute, one of the leading clinical trial research organizations in the world, Florida Cancer Specialists maintains an exceptional clinical trial research program that is unlike any other community practice in the nation. Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS has a comprehensive roster of national clinical trials that are available to patients across the state. In addition, the FCS network boasts two drug development units, including a dedicated Phase 1 trial program that rivals much larger academic medical centers and offers patients access to promising new therapies before the FDA approves them.
In-House Laboratory Services
Each FCS cancer center location provides accredited, state and federally-licensed in-house laboratories for all routine blood work. We perform all standard blood work on site, with some specialized specimens being transported daily to a central facility with technically-advanced analyzers for processing. Results are usually available within 24 hours.
The FCS pathology lab is a state-of-the-art facility with a highly-trained staff that includes five Hematopathologists and two surgical Pathologists to serve the needs of our practice. In collaboration with NeoGenomics, the FCS lab is able to provide both the technical analysis and the professional evaluation of all aspects of a comprehensive hematopathology report.
This includes histology, immunohistochemistry (IHC), in situ hybridization (ISH), flow cytometry, florescence in situ hybridization (FISH), and polymerase chain reaction (PCR).
Our pathologists are in regular contact with all of the clinicians, allowing immediate reporting of clinically significant information. Our turnaround times are greatly assisted by the central location for all testing and a courier system set up specifically for the needs of our group.
Outstanding Physician Leadership
FCS physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state’s leading hospitals. Our physicians also hold board and leadership positions with such prestigious statewide and national organizations as Florida Society of Clinical Oncology (FLASCO), Community Oncology Association (COA), American Society of Hematology (ASH) and American Society of Radiation Oncology (ASTRO).
In-House Specialty Pharmacy
Rx To Go is an oral oncolytic pharmacy located at the FCS corporate headquarters in Fort Myers, FL. Rx To Go specializes in delivering newer oral oncology medications to our patients throughout 41 states, where the pharmacy is licensed. This year, approximately 40% of all cancer drugs will be available in pill form, including the newer targeted therapies.
Because it is a part of the FCS network, both physicians and patients benefit from direct immediate access to in-house pharmacists, who are able to provide faster, superior service.
Fully-Integrated Electronic Medical Records
OncoEMR is a fully-integrated electronic medical records system developed in collaboration with several FCS physicians. Not only do all FCS physicians have 24/7 online and mobile access to patients’ health records, OncoEMR also offers both a patient portal (SeeYourChart), as well as a portal for referring physicians. Through OncoEMR, new physicians joining the practice can share patients’ charts with FCS colleagues, obtain lab and other test results usually within 24 hours and allow patients to have rapid access to their own pertinent medical information.